Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine-Reference-Cited by-同舟云学术

Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine

Published:2000-09 Issue:13 Volume:14 Page:1973-1978
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Haas David W,Arathoon Eduardo,Thompson Melanie A,de Jesus Pedro Rogiero,Gallant Joel E,Uip David E,Currier Judith,Noriega L. Miguel,Lewi David S,Uribe Patricia,Benetucci Jorge,Cahn Pedro,Paar David,White A. Clinton,Collier Ann C,Ramirez-Ronda Carlos H,Harvey Charlotte,Chung Mi-ok,Mehrotra Devan,Chodakewitz Jeffrey,Nguyen Bach-Yen

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference21 articles.

1. High Levels of HIV-1 in Plasma During All Stages of Infection Determined By Competitive PCR

2. Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma

3. Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection

4. HIV-1 RNA levels and the development of clinical disease

5. Antiretroviral Therapy for HIV Infection in 1998

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Why Molnupiravir Fails in Hospitalized Patients;mBio;2022-12-20

2. Modeling population heterogeneity in viral dynamics for chronic hepatitis C infection: Insights from Phase 3 telaprevir clinical studies;Journal of Pharmacokinetics and Pharmacodynamics;2015-08-20

3. Pharmacometrics of Viral Infections;Applied Pharmacometrics;2014

4. Specification of covariance structure in longitudinal data analysis for randomized clinical trials;Statistics in Medicine;2009

5. Efficacy, Safety, and Tolerability of Long-Term Combination Antiretroviral Therapy in Asymptomatic Treatment-Naïve Adults with Early HIV Infection;HIV Clinical Trials;2007-10